FDA Inspection 1234860 — Sheffield Pharmaceuticals, LLC

Sheffield Pharmaceuticals, LLC — FEI 1210513

The FDA completed an inspection of Sheffield Pharmaceuticals, LLC on June 18, 2025 in New London, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 18, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
New London, CT (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
2142521 CFR 820.184(f)DHR - UDI not included
310421 CFR 820.30(j)Design history file
356521 CFR 211.58Buildings not maintained in good state of repair
439121 CFR 211.180(e)(2)Items to cover on annual reviews